If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
SUNNYVALE, Calif., Oct. 6 (HSMN NewsFeed) — FlowCardia, Inc., a worldwide leader in the development of endovascular devices for the treatment of chronic total occlusions (CTOs), has launched the FlowMate Injector, which dramatically simplifies central l…
Devices, Interventional
FlowCardia, FlowMate Injector, CROSSER CTO
Posts on ‘October 6th, 2009’
FlowCardia, Inc. Launches FlowMate(TM) Injector to Optimize Performance of CROSSER(R) CTO Recanalization Catheter
Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
Gen-Probe Sales Force to Promote Prodesse’s FDA-Cleared, Highly Sensitive Assay for Influenza Transaction Expected to Provide Immediate Boost to Gen-Probe’s Non-GAAP Earnings and Revenue Growth Rate SAN DIEGO, Oct. 6 (HSMN NewsFeed) — Gen-Probe In…
Diagnostics, Acquisitions
Gen-Probe, Prodesse
US Spine Launches New PEEK Interbody Fusion System
BOCA RATON, Fla., Oct. 6–(HSMN NewsFeed)–US Spine(R) is pleased to announce the launch of the Phantom Plus(TM) Interbody Fusion System. Phantom Plus provides spine surgeons with next generation instrumentation and implants that offer a compliment to US S…
Devices, Orthopaedic, Neurosurgery
US Spine, Phantom Plus, Interbody Fusion, PEEK-OPTIMA, spine surgery
SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector
HORSHAM, Pa. and KENILWORTH, N.J., Oct. 6 (HSMN NewsFeed) — Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP ) announced today that the European Commission has approved SIMPONI(TM) (golimumab) as a once-monthly, subcutaneous therap…
Biopharmaceuticals, Regulatory
Schering-Plough, Centocor Ortho Biotech, SIMPONI, golimumab
CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves
ATLANTA, Oct. 6 (HSMN NewsFeed) — CryoLife, Inc., (NYSE: CRY ) an implantable biological laboratory device and cardiovascular tissue processing company, today announced that it has received a Humanitarian Use Device (HUD) designation from the Food and Drug…
Devices, Cardiology, FDA
CryoLife, CryoValve SG, heart valve
AtriCure Announces European Approval for its AtriClip System
WEST CHESTER, Ohio, Oct., 6–(HSMN NewsFeed)–AtriCure, Inc. (Nasdaq: ATRC ), a pharma device company and a leader in cardiac surgical ablation systems, today announced CE Mark approval for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion Sy…
Devices, Cardiology, Regulatory
AtriCure, AtriClip
